zinforo
pfizer ireland pharmaceuticals - ceftaroline fosamil - community-acquired infections; skin diseases, infectious; pneumonia - antibakterielle midler til systemisk brug, - zinforo is indicated for the treatment of the following infections in neonates, infants, children, adolescents and adults: , complicated skin and soft tissue infections (cssti), community-acquired pneumonia (cap) , consideration should be given to official guidance on the appropriate use of antibacterial agents.
aciclovir "pfizer" 25 mg/ml koncentrat til infusionsvæske, opløsning
pfizer aps - aciclovir - koncentrat til infusionsvæske, opløsning - 25 mg/ml
delepsine 100 mg enterotabletter
orion corporation - natriumvalproat - enterotabletter - 100 mg
delepsine 300 mg enterotabletter
orion corporation - natriumvalproat - enterotabletter - 300 mg
delepsine 500 mg enterotabletter
orion corporation - natriumvalproat - enterotabletter - 500 mg
delepsine 200 mg/ml orale dråber, opløsning
orion corporation - natriumvalproat - orale dråber, opløsning - 200 mg/ml
delepsine 60 mg/ml oral opløsning
orion corporation - natriumvalproat - oral opløsning - 60 mg/ml
delepsine 300 mg suppositorier
orion corporation - natriumvalproat - suppositorier - 300 mg
delepsine retard 300 mg depottabletter
orion corporation - natriumvalproat - depottabletter - 300 mg
delepsine retard 500 mg depottabletter
orion corporation - natriumvalproat - depottabletter - 500 mg